U.S. Markets open in 8 hrs 35 mins

MediPharm Labs Corp. (LABS.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.07500.0000 (0.00%)
At close: 03:59PM EDT

MediPharm Labs Corp.

151 John Street
Barrie, ON L4N 2L1

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees190

Key Executives

NameTitlePayExercisedYear Born
Mr. Keith StrachanCo-Founder & Pres455.3kN/AN/A
Mr. Greg HunterChief Financial Officer457.51kN/AN/A
Mr. David A. PidduckCEO & DirectorN/AN/AN/A
Mr. Patrick McCutcheonFounderN/AN/AN/A
Mr. Saravan SubramaniamVP of Operations & Supply ChainN/AN/AN/A
Mr. Geoffrey MarrExec. VP & Gen. CounselN/AN/AN/A
Mr. Brett MoonVP of SalesN/AN/AN/A
Mr. Kirk BinnsExec. VP of Global AccountsN/AN/AN/A
Mr. Nigel DewsburyHead of QualityN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Corporate Governance

MediPharm Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.